We have previously reported that syndecan-1 (CD138) up-regulates miR-331-3p expression by directly targeting neuropilin 2 (NRP2) and nucleus accumbens-associated protein 1 (NACC1) to mediate the EMT in prostate cancer cells [13]. The gene discussed is SDC1; the disease is prostate carcinoma.